Subscribe

Euglena Co., Ltd. (2931.T)

JPY351.00 +0.00 (+0.00%)
JP JPX Consumer Defensive Household & Personal Products
Address G-BASE Tamachi 108-0014
Tokyo, JP
CEO Tomohiro Wakahara
Website euglena.jp
IPO 2012-12-21
ISIN JP3944370000

Explore sections of this company profile

Description

Euglena Co., Ltd. is a Japanese enterprise specializing in the research, development, cultivation, and marketing of microalgae. Its operations are structured around two primary divisions: Healthcare Business and Energy/Environment Business. The company manufactures and sells a variety of euglena-derived food items and cosmetics. Additionally, it offers a broad portfolio of consumer goods, such as health foods, beverages, confectionery, and sports nutrition products. Furthermore, Euglena is engaged in pioneering biofuel and environmental technologies leveraging microalgae, and it makes strategic investments in the biotechnology sector. Its merchandise is distributed through numerous retail channels, including convenience stores, pharmacies, grocery stores, beauty parlors, and various specialty retailers. The company was established in Tokyo, Japan, in 2005.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
JPY351.00 +0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
1M
Beta
-0.09
Float Shares
104.73M
Free Float %
75.2%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-4.24% -9.98% -11.74% -9.52% -17.20% -9.07% -21.52% -58.51% -58.55% -77.32% +118.52%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
351.00
DCF (Unlevered) 3,888.63 +1,007.9%
DCF (Levered) 2,223.03 +533.3%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 0% Bullish
Rating 2026-05 Change
Strong Buy 0 0
Buy 0 0
Hold 1 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
1.77
Distress
Piotroski F-Score
4 / 9
Average
MOAT Score
3 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
  • Revenue growth Household & Personal Products: +3.3%
    +5.8% Q1'26: +10.6% (vs Q1'25)
  • EPS growth Household & Personal Products: +8.8%
    -21.9% Q1'26: +93.8% (vs Q1'25)
  • FCF margin FCF growth · Household & Personal Products: +44.8%
    +9.4% Q1'26: +0.0% (vs Q1'25)
  • EBIT margin Household & Personal Products: +9.9%
    +6.2% Q1'26: +6.3% (vs Q1'25)
  • ROIC Household & Personal Products: +8.2%
    +5.4% Q1'26: +5.4% (vs Q1'25)
  • Share dilution Household & Personal Products: +0.2%
    +1.6% Q1'26: +1.6% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Household & Personal Products: -0.51×
    4.28× Q1'26: 3.87× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (-0.10) × ERP
WACC = 64% × Ke + 36% × Kd (4.3%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Intrinsic value (base): 3,921.18 Current price: 351.00
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2016
actual
Dec 2017
actual
Dec 2018
actual
Dec 2019
actual
Dec 2020
actual
Dec 2021
actual
Dec 2022
actual
Dec 2023
actual
Dec 2024
actual
Dec 2025
actual
Dec 2026
1 Rev. Ana.
1 EPS Ana.
Dec 2027
1 Rev. Ana.
1 EPS Ana.
Dec 2028
1 Rev. Ana.
1 EPS Ana.
Dec 2029
1 Rev. Ana.
1 EPS Ana.
Dec 2030
1 Rev. Ana.
1 EPS Ana.
Revenue
11.10B
est: 11.10B (+0.0%)
13.89B
est: 14.50B (-4.2%)
15.17B
est: 15.40B (-1.5%)
13.97B
est: 18.60B (-24.9%)
13.32B
est: 23.70B (-43.8%)
27.54B
est: 15.50B (+77.7%)
44.39B
est: 48.00B (-7.5%)
46.48B
est: 44.90B (+3.5%)
47.62B
est: 52.70B (-9.6%)
50.37B
est: 48.30B (+4.3%)
51.90B
51.90B – 51.90B
+7.5% YoY
53.10B
53.10B – 53.10B
+2.3% YoY
54.40B
54.40B – 54.40B
+2.4% YoY
55.80B
55.80B – 55.80B
+2.6% YoY
57.40B
57.40B – 57.40B
+2.9% YoY
EBITDA
1.01B
est: -59.07M (+1,816.6%)
1.41B
est: -77.17M (+1,931.1%)
-613.68M
est: -81.96M (-648.8%)
-6.50B
est: -98.99M (-6,470.2%)
-1.09B
est: -126.13M (-763.3%)
-3.50B
est: -82.49M (-4,141.4%)
-359.00M
est: -255.45M (-40.5%)
1.51B
est: -238.95M (+730.3%)
3.90B
est: 18.81B (-79.3%)
6.47B
est: 17.24B (-62.5%)
18.52B
18.52B – 18.52B
+7.5% YoY
18.95B
18.95B – 18.95B
+2.3% YoY
19.41B
19.41B – 19.41B
+2.4% YoY
19.91B
19.91B – 19.91B
+2.6% YoY
20.48B
20.48B – 20.48B
+2.9% YoY
EBIT
693.96M
est: -873.97M (+179.4%)
950.94M
est: -1.14B (+183.3%)
-1.38B
est: -1.21B (-13.8%)
-7.46B
est: -1.46B (-409.4%)
-1.81B
est: -1.87B (+3.1%)
-5.25B
est: -1.22B (-330.4%)
-3.53B
est: -3.78B (+6.5%)
-1.46B
est: -3.54B (+58.6%)
302.00M
est: 15.34B (-98.0%)
3.12B
est: 14.06B (-77.8%)
15.11B
15.11B – 15.11B
+7.5% YoY
15.46B
15.46B – 15.46B
+2.3% YoY
15.84B
15.84B – 15.84B
+2.4% YoY
16.25B
16.25B – 16.25B
+2.6% YoY
16.71B
16.71B – 16.71B
+2.9% YoY
Net Income
673.34M
est: 1.22B (-44.9%)
785.89M
est: 1.11B (-29.5%)
-1.25B
est: -967.07M (-29.5%)
-9.80B
est: -6.76B (-45.0%)
-1.49B
est: 3.68B (-140.4%)
-4.03B
est: -1.57B (-156.5%)
-2.67B
est: 1.01B (-365.2%)
-2.65B
est: -1.54B (-71.8%)
-650.00M
est: -805.35M (+19.3%)
-805.00M
est: 191.10M (-521.2%)
382.20M
382.20M – 382.20M
+100.0% YoY
655.20M
655.20M – 655.20M
+71.4% YoY
1.79B
1.79B – 1.79B
+172.9% YoY
2.78B
2.78B – 2.78B
+55.7% YoY
3.60B
3.60B – 3.60B
+29.4% YoY
SGA
6.97B
est: 2.78B (+150.6%)
8.70B
est: 3.63B (+139.6%)
11.51B
est: 3.86B (+198.5%)
9.77B
est: 4.66B (+109.7%)
9.81B
est: 5.93B (+65.3%)
20.07B
est: 3.88B (+417.0%)
31.11B
est: 12.02B (+158.8%)
30.03B
est: 11.24B (+167.1%)
28.86B
est: 34.94B (-17.4%)
31.91B
est: 32.02B (-0.4%)
34.41B
34.41B – 34.41B
+7.5% YoY
35.21B
35.21B – 35.21B
+2.3% YoY
36.07B
36.07B – 36.07B
+2.4% YoY
37.00B
37.00B – 37.00B
+2.6% YoY
38.06B
38.06B – 38.06B
+2.9% YoY
EPS
8.18
est: 9.10 (-10.1%)
9.44
est: 8.30 (+13.7%)
-14.70
est: -7.20 (-104.2%)
-107.25
est: -50.30 (-113.2%)
-16.00
est: 27.40 (-158.4%)
-39.25
est: -11.70 (-235.5%)
-23.83
est: 7.50 (-417.7%)
-22.75
est: -11.50 (-97.8%)
-4.84
est: -5.90 (+18.0%)
-5.90
est: 1.40 (-521.4%)
2.80
2.80 – 2.80
+100.0% YoY
4.80
4.80 – 4.80
+71.4% YoY
13.10
13.10 – 13.10
+172.9% YoY
20.40
20.40 – 20.40
+55.7% YoY
26.40
26.40 – 26.40
+29.4% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-15 C- 1/5 1/5 1/5 1/5 2/5 1/5 3/5
2026-05-14 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-05-13 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-05-12 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-05-11 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-05-08 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-05-07 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-05-01 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-04-30 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-04-28 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-04-27 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-04-24 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-04-23 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-04-22 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-04-21 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-04-20 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-04-17 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-04-16 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
2.61B
OE per share TTM
19.12
Owner's Yield
4.99%
Maintenance CapEx ratio
Maint CapEx / Avg PPE
15.1%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
Total invested
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock Held by 30 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 State Street SPDR S&P International Small Cap ETF GWX 0.01% 106.1K 0.40%
2 Schwab International Small-Cap Equity ETF SCHC 0.01% 521.7K 0.06%
3 Dimensional - International Small Cap ETF DFIS 0.00% 258.6K 0.39%
4 iShares Core TOPIX ETF 1475.T 0.00% 744.1K 0.05%
5 Amundi Japan TOPIX II UCITS ETF EUR Dist JPNU.L 0.00% 28.5K 0.45%
6 State Street SPDR Portfolio Developed World ex-US ETF SPDW 0.00% 1.52M 0.03%
7 Dimensional International Sustainability Core 1 ETF DFSI 0.00% 33.4K 0.24%
8 Vanguard FTSE Developed Asia Pacific All Cap Index ETF VA.TO 0.00% 5.3K 0.22%
9 Vanguard FTSE All-World ex-US Small-Cap ETF VSS 0.00% 228.9K 0.06%
10 Dimensional - International Core Equity Market ETF DFAI 0.00% 170.6K 0.18%

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
3.48M
Shares Outstanding
139.25M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Tomohiro Wakahara Representative Executive Officer, Co-CEO, Finance Officer & Director 19M male
Hiroko Uemura Rep. Exe. Officer, Co-CEO, Head of Human Resources, Domestic Sales and New Business Dev. & Director female
Kengo Suzuki Executive Officer & Chief Technology Officer
Korehiro Odate Executive Officer & Head of Energy Company male
Midori Watabe Chief Future Officer female
Mitsuru Izumo President & Representative Director male
Shoko Takahashi Executive Officer & Bioinformatics Business Head female
Yasuhiro Fukutomi Special Officer & CSO male
Yukihiro Maru Professional Officer & CRO
Chihiro Kato Chief Creative Director
Yuko Suzuki Executive Officer of Legal Affairs
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits